While SARS coronaviruses can evade immune responses by blocking the induction of interferons and reducing IFN‐driven responses, evidence from SARS‐CoV‐1 coronavirus suggests that type 1 IFN derived from plasmacytoid DCs can control infection [27]. This evidence concerns the gene IFNA1 and infection.